Pacira Biosciences Inc PCRX:NASDAQ

Last Price$38.22NASDAQ Previous Close - Last Trade as of 3:59PM ET 8/16/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$35.00 (15)
Ask (Size)$46.46 (1)
Day Low / HighN/A - N/A
Volume540.0 K
 

View Pharmaceuticals: Other IndustryPeer Comparison as of 08/16/2019

 

Pacira Biosciences Inc ( NASDAQ )

Price: $38.22
Change: -0.72 (1.85%)
Volume: 540.0 K
3:59PM ET 8/16/2019
 
 

Prestige Consumer Healthcare Inc ( NYSE )

Price: $32.91
Change: +0.11 (0.34%)
Volume: 258.8 K
6:30PM ET 8/16/2019
 
 

Corcept Therapeutics Inc ( NASDAQ )

Price: $12.99
Change: +0.33 (2.61%)
Volume: 651.1 K
4:00PM ET 8/16/2019
 
 

Madrigal Pharmaceuticals Inc ( NASDAQ )

Price: $92.47
Change: +2.51 (2.79%)
Volume: 117.3 K
4:00PM ET 8/16/2019
 
 

Supernus Pharmaceuticals Inc ( NASDAQ )

Price: $27.11
Change: +0.10 (0.37%)
Volume: 441.4 K
3:59PM ET 8/16/2019
 

Read more news Recent News

Insider Trends: Pacira Biosciences Sees 90 Days of Insider Buying Trend Reducing with Share Sale
4:18PM ET 8/16/2019 MT Newswires

On Aug 14, 2019, Chief Administrative Officer, Kristen Marie Williams, executed a sale of 6,252 shares in Pacira Biosciences (PCRX) for $246,891. After...

Consensus for Pacira Biosciences 2019 Earnings Targeted Lower but 2020 Projections Raised
7:46AM ET 8/13/2019 MT Newswires

The 2019 and 2020 full year forecasted earnings estimates for Pacira Biosciences Inc's (NASDAQ:PCRX, Recent Price: 40.39) have been changed. The consensus...

2019, 2020 Earnings Estimates for Pacira Biosciences Scaled Down
7:41AM ET 8/10/2019 MT Newswires

The full year forecasted earnings estimates for 2019 and 2020 for Pacira Biosciences Inc (NASDAQ:PCRX, Recent Price: 42.47) have been reduced. The...

--Analyst Actions: BMO Lowers Pacira Pharmaceuticals PT to $43 From $46, Keeps Market Perform Rating
2:56PM ET 8/09/2019 MT Newswires

Price: 42.67, Change: +0.31, Percent Change: +0.74 ...

View all Commentary and Analysis

Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q2 2019 Results - Earnings Call Transcript
12:49PM ET 8/08/2019 Seeking Alpha

Biotech Stocks Getting Ready To Explode
11:38AM ET 6/17/2019 Seeking Alpha

BIIB Is For Buy-O-Gen
10:30AM ET 6/12/2019 Seeking Alpha

A Biotech-Friendly Event In An Unfriendly Healthcare Market
4:56PM ET 6/02/2019 Seeking Alpha

Company Profile

Business DescriptionPacira Biosciences, Inc. operates as a holding company, which engages in the development, commercialization, and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ. View company web site for more details
Address5 Sylvan Way
Parsippany, New Jersey 07054
Phone+1.973.254.3560
Number of Employees518
Recent SEC Filing08/16/20194
Chairman, Chief Executive & Operating OfficerDavid M. Stack
PresidentMax Reinhardt
Chief Financial OfficerCharles A. Reinhart
Vice President-Research & DevelopmentVladimir Kharitonov

Company Highlights

Price Open$39.00
Previous Close$38.22
52 Week Range$35.07 - 55.00
Market Capitalization$1.6 B
Shares Outstanding41.6 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement11/07/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings224.82
Earnings per Share$0.26
Beta vs. S&P 500N/A
Revenue$337.3 M
Net Profit Margin2.04%
Return on Equity2.35%

Analyst Ratings as of 08/09/2019

Buy
8
Overweight
0
Hold
6
Underweight
0
Sell
1
Consensus RecommendationConsensus Icon
Powered by Factset